loading
Schlusskurs vom Vortag:
$1.97
Offen:
$1.98
24-Stunden-Volumen:
54,368
Relative Volume:
0.40
Marktkapitalisierung:
$75.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.27M
KGV:
-12.32
EPS:
-0.164
Netto-Cashflow:
$-7.70M
1W Leistung:
+17.78%
1M Leistung:
-24.91%
6M Leistung:
-2.42%
1J Leistung:
+88.79%
1-Tages-Spanne:
Value
$1.922
$2.07
1-Wochen-Bereich:
Value
$1.75
$2.0963
52-Wochen-Spanne:
Value
$0.9016
$3.349

Okyo Pharma Limited Stock (OKYO) Company Profile

Name
Firmenname
Okyo Pharma Limited
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
4
Name
Twitter
Name
Nächster Verdiensttermin
2025-12-03
Name
Neueste SEC-Einreichungen
Name
OKYO's Discussions on Twitter

Vergleichen Sie OKYO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
OKYO
Okyo Pharma Limited
2.02 74.09M 0 -13.27M -7.70M -0.164
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
444.64 110.88B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
726.21 72.79B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
890.11 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
404.46 54.85B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
189.85 41.41B 447.02M -1.18B -906.14M -6.1812

Okyo Pharma Limited Stock (OKYO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-12-08 Eingeleitet B. Riley Securities Buy

Okyo Pharma Limited Aktie (OKYO) Neueste Nachrichten

pulisher
Dec 10, 2025

B. Riley Begins Coverage on OKYO Pharma (NASDAQ:OKYO) - Defense World

Dec 10, 2025
pulisher
Dec 09, 2025

OKYO Pharma (NASDAQ:OKYO) Stock Rating Upgraded by B. Riley - MarketBeat

Dec 09, 2025
pulisher
Dec 08, 2025

B. Riley Initiates Coverage on OKYO Pharma With Buy Rating, $5 Price Target - marketscreener.com

Dec 08, 2025
pulisher
Dec 08, 2025

B.Riley initiates coverage on OKYO Pharma stock with Buy rating - Investing.com Nigeria

Dec 08, 2025
pulisher
Dec 05, 2025

How OKYO Pharma Limited (OK11) stock compares with top peersGlobal Markets & Long-Term Safe Investment Plans - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

What is the fair value estimate for OKYO Pharma Limited (OK11) stock in 2025Market Sentiment Report & Technical Pattern Alert System - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Is OKYO Pharma Limited (OK11) stock a top pick for value investors2025 Trade Ideas & AI Powered Market Entry Strategies - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Okyo Pharma chairman acquires 27,051 company shares - MSN

Dec 04, 2025
pulisher
Dec 04, 2025

Is OKYO Pharma Limited stock trading near support levelsWeekly Profit Analysis & Daily Chart Pattern Signal Reports - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

OKYO Pharma chairman-linked entity acquires additional shares on NASDAQ - Investing.com

Dec 03, 2025
pulisher
Dec 03, 2025

OKYO Pharma’s Chairman Increases Stake Amidst Phase 2 Trial Completion - TipRanks

Dec 03, 2025
pulisher
Dec 03, 2025

Gabriele Cerrone increases stake in OKYO Pharma with share purchase - Investing.com

Dec 03, 2025
pulisher
Dec 03, 2025

OKYO Pharma Limited Executive Chairman Gabriele Cerrone Acquires Additional Shares in Company - Quiver Quantitative

Dec 03, 2025
pulisher
Dec 03, 2025

Gabriele Cerrone increases stake in OKYO Pharma with share purchase By Investing.com - Investing.com UK

Dec 03, 2025
pulisher
Dec 03, 2025

OKYO Pharma (NASDAQ: OKYO) chairman raises holding after buying 27,051 shares - Stock Titan

Dec 03, 2025
pulisher
Dec 03, 2025

Why OKYO Pharma Limited stock is a must watch in 2025Market Growth Report & Comprehensive Market Scan Reports - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

OKYO Pharma executive chair increases stake with additional share purchase - Proactive financial news

Dec 03, 2025
pulisher
Dec 01, 2025

OKYO Pharma (OKYO) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025
pulisher
Nov 27, 2025

Holdings of OKYO Pharma Limited (OKYO) are aligned with the stars - Setenews

Nov 27, 2025
pulisher
Nov 26, 2025

Decliners Report: Will OKYO Pharma Limited stock remain a Wall Street favoriteRecession Risk & Advanced Swing Trade Entry Plans - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 23, 2025

Okyo Pharma chairman acquires 82,018 company shares - MSN

Nov 23, 2025
pulisher
Nov 22, 2025

Panetta Partners increases stake in OKYO Pharma with purchase of 82,018 shares - Investing.com Australia

Nov 22, 2025
pulisher
Nov 22, 2025

OKYO Pharma founder increases his buys shares - Proactive financial news

Nov 22, 2025
pulisher
Nov 22, 2025

Operating cash flow per share of OKYO Pharma Limited – NASDAQ:OKYO - TradingView

Nov 22, 2025
pulisher
Nov 21, 2025

Okyo Pharma chairman increases stake with new share acquisition By Investing.com - Investing.com Nigeria

Nov 21, 2025
pulisher
Nov 21, 2025

OKYO Pharma stock rises after Chairman increases stake By Investing.com - Investing.com Nigeria

Nov 21, 2025
pulisher
Nov 21, 2025

OKYO Pharma stock rises after Chairman increases stake - Investing.com India

Nov 21, 2025
pulisher
Nov 21, 2025

OKYO Pharm Chairman and Founder acquires shares - MSN

Nov 21, 2025
pulisher
Nov 21, 2025

OKYO Pharma’s Chairman Increases Stake with Recent Share Acquisition - TipRanks

Nov 21, 2025
pulisher
Nov 21, 2025

Okyo Pharma chairman increases stake with new share acquisition - Investing.com India

Nov 21, 2025
pulisher
Nov 21, 2025

OKYO Pharma Limited Executive Chairman Acquires Additional Shares, Totaling 10.5 Million Holdings - Quiver Quantitative

Nov 21, 2025
pulisher
Nov 21, 2025

OKYO Pharma Announces Chairman and Founder Acquires Shares - marketscreener.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is OKYO Pharma Limited (OK11) stock trading at attractive multiples2025 Pullback Review & Capital Efficient Trade Techniques - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why OKYO Pharma Limited (OK11) stock signals breakout potential2025 Big Picture & Fast Gaining Stock Reports - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Dry Eye Disease Market Size was ~USD 3.76 Billion in 2023 and expected to Grow by 2034, Analysed DelveInsight - Barchart.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is OKYO Pharma Limited stock oversold or undervaluedRisk Management & Stepwise Trade Signal Implementation - newser.com

Nov 20, 2025

Finanzdaten der Okyo Pharma Limited-Aktie (OKYO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$38.26
price up icon 0.45%
$95.17
price up icon 0.01%
$31.24
price up icon 1.00%
$95.73
price down icon 0.12%
biotechnology ONC
$322.68
price up icon 1.25%
$189.85
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):